Danaher Corporation vs Pfizer, Inc. — Stock Comparison

Danaher Corporation (DHR) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

Q·Score Winner
Danaher Corporation
DHR7.7/10vs 6.4/10

Danaher Corporation scores ahead of Pfizer, Inc. on Q·Score (7.7 vs 6.4 out of 10), led by Sentiment (8.2 vs 5.3) and Health (9.1 vs 7). Analyst consensus targets imply greater upside for DHR (+36.8%) than for PFE (+15.8%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
DHRPFE

Q·Score Breakdown

7.7
Bullish
Overall
6.4
Neutral
6.7
Quality
6.4
9.1
Health
7
6.2
Growth
5.1
8.6
Valuation
7.7
8.2
Sentiment
5.3
DHR

Clean balance sheet with low leverage (0.4× debt-to-equity).

PFE

Forward P/E of 8.9× is low relative to sector peers.

earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+36.8%
Target $242.35
23 analysts
Neutral
+15.8%
Target $29.19
27 analysts

Fundamentals

DHR
PFE
34.3×
Trailing P/E
19.2×
19.2×
Forward P/E
8.9×
14.89%
Profit Margin
11.83%
58.99%
Gross Margin
74.80%
7.08%
ROE
8.31%
3.70%
Revenue Growth
5.40%
9.80%
Earnings Growth
-10.10%
0.83
Beta
0.29
Dividend Yield
6.61%
$125.4B
Market Cap
$143.7B
52-Week Range
DHR
$16120% of range$243
PFE
$2337% of range$29

Frequently Asked Questions

DHR vs PFE: which stock scores better overall?

Based on Q·Score, Danaher Corporation (DHR) scores 7.7/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: DHR or PFE?

Danaher Corporation (DHR) scores higher on Growth (6.2/10 vs 5.1/10). Danaher Corporation reports revenue growth (3.7% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is DHR or PFE more attractively valued?

Danaher Corporation (DHR) scores higher on Valuation (8.6/10 vs 7.7/10). DHR trades at 19.2× P/E versus PFE at 8.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about DHR vs PFE?

There are 23 analysts covering DHR with a consensus price target of $242.35, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: DHR or PFE?

Danaher Corporation (DHR) scores higher on Quality (6.7/10 vs 6.4/10). Net profit margin: DHR at 14.9%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: DHR or PFE?

Danaher Corporation (DHR) scores higher on Financial Health (9.1/10 vs 7/10). Market beta: DHR at 0.83, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of DHR and PFE?

Danaher Corporation (DHR) has a market capitalisation of $125.4B, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do DHR or PFE pay dividends?

DHR does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026